TABLE 3

Spearman correlation coefficient ρ for the association of lipoproteins and particle size with coronary artery calcification score

Men
Women
Nondiabetic (n = 91)
Diabetic (n = 101)
Nondiabetic (n = 104)
Diabetic (n = 93)
ρPρPρPρP
Small VLDL (v1,v2) (nmol/l)0.050.60.10.3−0.010.90.090.4
Medium VLDL (v3,v4) (nmol/l)0.130.20.110.20.180.06−0.020.8
Large VLDL (v5,v6,chylo) (nmol/l)0.270.010.170.10.270.0050.040.7
Total VLDL particles (nmol/l)0.130.20.150.10.050.60.110.3
VLDL size (nm)0.110.30.020.80.230.020.060.6
IDL (nmol/l)0.040.70.110.30.110.30.10.3
Small LDL (L1) (nmol/l)0.230.030.020.80.190.050.060.6
Large LDL (L2,L3) (nmol/l)−0.030.80.080.40.060.60.050.6
Total LDL + IDL particles (nmol/l)0.20.0460.130.20.250.0090.120.3
LDL size (nm)−0.160.1−0.040.7−0.130.2−0.040.7
Small HDL (H1,H2) (μmol/l)0.10.40.140.20.020.8−0.160.1
Medium HDL (H3) (μmol/l)−0.0350.7−0.120.20.030.8−0.010.9
Large HDL (H4,H5) (μmol/l)−0.210.04−0.110.3−0.250.009−0.060.5
Total HDL particles (μmol/l)−0.100.3−0.040.7−0.110.2−0.160.1
HDL size (nm)−0.230.02−0.040.7−0.300.002−0.090.4
  • Chylo, chylomicron.